
Journal of Medicinal Chemistry p. 674 - 688 (1994)
Update date:2022-08-03
Brown
Brown
Bickett
Chambers
Davies
Deaton
Drewry
Foley
McElroy
Gregson
McGeehan
Myers
Norton
Salovich
Schoenen
Ward
Systematic modification of the presumed P1 side chain in a series of (carboxyalkyl)amino-based inhibitors of matrix metalloproteinases enabled identification of the 2-(1,3-dihydro-1,3-dioxo-2H-benz[f]isoindol-2-yl)ethyl group as a preferred substituent imparting potent inhibition of the enzymes collagenase and gelatinase. It was subsequently found that the P2'-P3' residues in this series could be replaced by small non-peptide residues, while maintaining inhibitory potency. The imide group in this series of compounds can undergo autocatalytic hydrolysis under neutral conditions.
View MoreJiangsu Allyrise Pharmaceutical Co., Ltd.(expird)
Contact:+86-523-86818997
Address:Taizhou,Jiangsu Province,CHINA
Contact:+86-371-86058576
Address:NO.32, Jingsan Road, Zhengzhou, China
LinHai Cina Chemical Co., LTD.
Contact:0576-85580989
Address:Pharma-chem zone,Duqiao,Linhai,Zhejiang,China
website:http://www.vanzpharm.com/en/index.html
Contact:86-27-84492310
Address:FANHU INDUSTRY PARK
Nanjing Fubang Chemical Co.,Ltd
Contact:+86-25-83179199
Address:5F,Tianzheng international plaza,No399 Zhongyang Road ,Nanjing China
Doi:10.1021/jo00085a038
(1994)Doi:10.1016/S0040-4039(00)73719-1
(1993)Doi:10.1016/j.tet.2006.05.050
(2006)Doi:10.1021/ic50217a054
(1981)Doi:10.1021/jo00086a034
(1994)Doi:10.1016/j.tetlet.2014.01.009
(2014)